Publisher
Springer Science and Business Media LLC
Reference39 articles.
1. Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021;71:209–49.
2. Carr C, Ng J, Wigmore T. The side effects of chemotherapeutic agents. Curr Anaesth Crit Care. 2008;19:70–79.
3. Al-Balas Q, Al-Shar’i NA, Banisalman K, Hassan M, Aljabal GA, Almaaytah A, et al. Design, Synthesis and Biological Evaluation of Potential Novel Zinc Binders Targeting Human Glyoxalase-I; A Validated Target for Cancer Treatment Jordan Journal of Pharmaceutical Sciences, 2018;11:25–37.
4. Al-Balas QA, Hassan MA, Al-Shar'i NA, Mhaidat NM, Almaaytah AM, Al-Mahasneh FM, et al. Novel glyoxalase-I inhibitors possessing a “zinc-binding feature” as potential anticancer agents. Drug Des Devel Ther. 2016;10:2623–9.
5. Al-Balas QA, Hassan MA, Al-Shar'i NA, El-Elimat T, Almaaytah AM. Computational and experimental exploration of the structure–activity relationships of flavonoids as potent glyoxalase-I inhibitors. Drug Dev Res. 2018;79:58–69.